Cell Therapy Next Current Issue

08 01 2024

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

Looking back, looking forward: Penn’s CAR-T program continues path of progress Katrina Altersitz
As CAR-T emerges, stem cell transplants for lymphoma in ‘marked decline’ Drew Amorosi
CAR-T delivers ‘amazing’ drug-free remission in autoimmune diseases Josh Friedman
CAR-T recipients report higher rates of ‘potentially serious’ toxicities Josh Friedman
CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia Matthew Shinkle
FDA official says CAR-T ‘incredibly beneficial’ despite secondary malignancy risk Josh Friedman
‘Gratifying’ results show ‘incredible step forward’ for off-the-shelf T-cell therapies Josh Friedman
‘Off-the-shelf’ cell therapy shows ‘very encouraging’ results for B-cell malignancies Matthew Shinkle